Skip to content
AwardedBelgiumGoods

Procurement of antiviral, Favipiravir 200mg tablets for Andes virus

Published
Published 29 June 2026

Overview

The European Commission's DG HERA procured Favipiravir 200mg tablets as an urgent medical countermeasure for Andes virus treatment in response to requests from two Member States. The contract was awarded to betapharm Arzneimittel GmbH for €487,440 on 28 May 2026.

Key details

Country
Belgium
Status
Awarded
Category
Goods
Procedure
Direct
Published
29 June 2026
Classification (CPV)
Medical equipments, pharmaceuticals and personal care products

Award outcome

Awarded value
€487,440
Award date
28 May 2026
Contract period
— → 27 July 2026
Winner
  • betapharm Arzneimittel GmbH

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    29 June 2026

Contracting authority

  • European Commission, DG HERA - European Health Emergency Preparedness and Response Authority

    Procuring entity

    Brussels, Belgium

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Procurement of antiviral, Favipiravir 200mg tablets for Andes virus — won by betapharm Arzneimittel GmbH — Skim